Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole

Clinical Microbiology and Infection

Volumn 9, Issue 7, 2003, Pages 750-753

  Bosma, F ^a   Voss, A ^a   van Hamersvelt, H W ^a   de Sevaux R G L ^a   Biert, J ^a   Kullberg, B J ^a   Melchers, W G J ^a   Verweij, P E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fingerprinting; Scedosporium apoispermum; Voriconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOSPORIN A; DNA; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TERBINAFINE; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOPSY; BIOASSAY; BRONCHOPNEUMONIA; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DEATH; DNA FINGERPRINTING; DRUG WITHDRAWAL; FEMUR FRACTURE; FRACTURE TREATMENT; FUNGAL STRAIN; FUNGUS CULTURE; GENOTYPE; GRAFT REJECTION; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PATHOGENICITY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RECIPIENT; SCEDOSPORIUM APIOSPERMUM; SEPSIS; SKIN BIOPSY; SKIN DEFECT; STRAIN DIFFERENCE; TREATMENT OUTCOME;

FUNGI; PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM;

EID: 0042527258     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00596.x     Document Type: Article

References (23)

1. Yao M, Messner AH. Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 2001; 110(4): 377-80.
2. Nesky MA, McDougal EC, Peacock Jr JE. Pseudoallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudoallescheriasis. Clin Infect Dis 2000; 31: 673-7.
3. Piper JP, Golden J, Brown D, Broestler J. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 1990; 9: 674-5.
4. Jabado N, Casanova JL, Haddad E et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998; 27: 1437-41.
5. Fisher JF, Shadomy S, Teabeaut R et al. Near-drowning complicated by brain abscess due to Petriellidum boydii. Arch Neurol 1982; 39: 511-13.
6. Defontaine A, Zouhair R, Cimon B et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol 2002; 40(6): 2108-14.
7. Simarro E, Marin F, Morales A, Sanz E, Perez J, Ruiz J. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome. Clin Microbiol Infect 2001; 7: 639-47.
8. Idigoras P, Perez-Trallero E, Pineiro L et al. Disseminated infection and colonization by Scedosporium prolificans. A review of 18 cases 1990-1991. Clin Infect Dis 2001; 32: e158-65.
9. Pimentel ERA, Castro LGM, Cuce LC et al. Treatment of chromomycosis by cryosurgery with liquid nitrogen: a report on eleven cases. J Dermatol Surg Oncol 1989; 15: 72-7.
10. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39(3): 954-8.
11. Carrilo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001; 45(7): 2151-3.
12. Meletiadis J, Meis JF, Mouton JW et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46(1): 62-8.
13. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-71.
14. Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 1998; 36: 1436-8.
15. Munoz P, Marin M, Tornero P, Martin Rabadan P, Rodriguez-Creixems M, Bouza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000; 31: 1499-501.
16. Alvarez M, Lopez Ponga B, Rayon C et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33(12): 3290-5.
17. Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 1989; 106(1): 13-22.
18. Guerro A, Torres P, Duran MT, Ruiz-Diez B, Rosales M, Rodriguez-Tudela JL. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357: 1267-8.
19. Perea S, Pennick GJ, Modak A et al. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob Agents Chemother 2000; 44: 1209-13.
20. Ruiz-Diez B, Martin-Diez F, Rodriguez-Tudela JL, Alvarez M, Martinez-Suarez JV. Use of random amplification of polymorphic DNA (RAPD) and PCR fingerprinting for genotyping a Scedosporium prolificans (inflatum) outbreak in four leukemic patients. Curr Microbiol 1997; 35: 86-90.
21. Canet JJ, Pagerols X, Sanchez C, Vives P, Garau J. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin Microbiol Infect 2001; 7(11): 648-50.
22. Debeaupuis JP, Sarfati J, Chazalet V, Latge JP. Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus. Infect Immun 1997; 65: 3080-5.
23. Zouhair R, Defontaine A, Ollivier C et al. Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA. J Med Microbiol 2001; 50(10): 925-32.